US 8258280
Plasmodium vivax hybrid circumsporozoite protein and vaccine
granted A61KA61K2039/55566A61K39/015
Quick answer
US patent 8258280 (Plasmodium vivax hybrid circumsporozoite protein and vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Sep 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/55566, A61K39/015, A61P, A61P33/02